Moderna Total Long Term Liabilities 2017-2024 | MRNA

Moderna total long term liabilities for the quarter ending September 30, 2024 were $1.675B, a 4.04% increase year-over-year.

  • Moderna total long term liabilities for 2023 were $1.557B, a 14.07% decline from 2022.
  • Moderna total long term liabilities for 2022 were $1.812B, a 29.8% increase from 2021.
  • Moderna total long term liabilities for 2021 were $1.396B, a 260.72% increase from 2020.

Moderna Total Long Term Liabilities 2017-2024 | MRNA

  • Moderna total long term liabilities for 2023 were $1.557B, a 14.07% decline from 2022.
  • Moderna total long term liabilities for 2022 were $1.812B, a 29.8% increase from 2021.
  • Moderna total long term liabilities for 2021 were $1.396B, a 260.72% increase from 2020.